Beta-Amyloid (1-40), HFIP-Treated

HFIP-treated Aβ(1-40) is prepared to reduce pre-existing β-sheet-rich aggregates and provide a more homogeneous starting material for controlled aggregation studies.

• controlled Aβ40 aggregation
• oligomerization and fibrillogenesis
• amyloid assay standardization
• Thioflavin T workflows

HFIP treatment is a preparation attribute rather than a covalent sequence change. Keep it distinct from untreated Aβ40 because aggregation kinetics can depend strongly on pretreatment history.

1. In Vitro Characterization of Conditions for Amyloid-β Peptide Oligomerization and Fibrillogenesis